Sean M. Ronnekleiv‐Kelly
Papers
1
Total Citations
33
H-Index
1
About
Sean M. Ronnekleiv‐Kelly is a surgical oncologist whose research focuses on optimizing outcomes in pancreatic and hepatobiliary surgery, with a particular emphasis on cost-effectiveness and minimally invasive techniques. His major contributions center on evaluating the economic and clinical trade-offs between open and minimally invasive approaches for complex procedures. In his highly cited 2018 study, "Analysis of 90-day cost for open versus minimally invasive distal pancreatectomy," he demonstrated that minimally invasive distal pancreatectomy is associated with significantly lower 90-day costs—driven by reduced hospital stays and fewer complications—without compromising oncologic outcomes. This work has been cited over 30 times, reflecting its impact on surgical decision-making and healthcare policy. Beyond this, Ronnekleiv‐Kelly has advanced the understanding of patient selection for laparoscopic and robotic pancreatic resections, helping to define best practices in the field. His research bridges the gap between surgical innovation and practical value-based care, making him a key voice in the movement toward cost-conscious, high-quality surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1